standard dose capecitabine
SHEBA-14-1061-YL-CTIL
Phase 1 small_molecule active
Quick answer
standard dose capecitabine for Rectal Neoplasms is a Phase 1 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Rectal Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active